Chemical Structure (Ultramicrosize Griseofulvin Tablets 1)
Ultramicrosize Griseofulvin Tablet, Coated
Product Images NDC 0115-1725
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ultramicrosize Griseofulvin (NDC 0115-1725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
125 mg, 100 Tablets (NDC 0115-1724-01)
NDC 0115-1724-01 is a medication called Ultramicrosize Griseofulvin. Each tablet contains 125mg of the medication, and the usual dosage information can be found in the accompanying outsert. The medication should be stored in a USP-controlled room temperature of 20-25°C and in a resistant container to prevent light exposure. This medication is manufactured by ANI Pharmaceuticals and distributed by Amneal Pharmaceuticals.*
250 mg, 100 Tablets (NDC 0115-1725-01)
This is a description of Ultramicrosize Griseofulvin Tablets, USP with a dosage of 250mg per tablet. The complete prescribing information is included and advises to keep the medication in a tight and light-resistant container. The medication should be stored at 20°C to 25°C (68°F to 77°F) and out of reach of children. The tablets are manufactured by ANI Pharmaceuticals, Inc in Baudti, MN, and are sold by Amneal Phamaceuticals LLC in Bridgewater, NJ. The revision date for this information is December 2018.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
